ClearUP Longitudinal Pilot Study

NCT03888274 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-04-02

Study results available
· View outcomes & findings →

Summary

Single arm, open label pilot study assessing the longitudinal home use of ClearUp Sinus Pain Relief for four weeks.

Conditions

  • Sinus Pain
  • Congestion

Interventions

DEVICE

ClearUP Sinus Pain Relief

Microcurrent Device Treatment

Sponsors & Collaborators

  • Tivic Health Systems

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
71 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-29
Primary Completion
2019-02-13
Completion
2019-03-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03888274 on ClinicalTrials.gov